PMV Pharmaceuticals, Inc. (PMVP) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts PMVP Hot Sheet
Join SI Premium – FREE
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q3 EPS of ($0.40), in-line with the analyst estimate of ($0.40).
For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Simmons First National Corp (SFNC) Misses Q2 EPS by 2c
- Grok launches automated task scheduling with email triggers
- Private Bancorp of America, Inc. (PBAM) Tops Q2 EPS by 26c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
